Skip to content

Clinical trials

Completed Respiratory Syncytial Virus Infections trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Status: Completed Country / region: Australia Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20101
20144
20153
20163
20182
20192
20201
20213
20232
20246
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Sanofi Pasteur, a Sanofi Company4
MedImmune LLC3
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.2
Alios Biopharma Inc.2
Alnylam Pharmaceuticals2
Shanghai Ark Biopharmaceutical Co., Ltd.2
Ablynx, a Sanofi company1
AstraZeneca1
Biota Scientific Management Pty Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections32
Virus Diseases2
Paramyxoviridae Infections1
Premature Birth1
Respiratory Tract Infections1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.